ReviewFuture oncology (London, England)2018
An overview of meningiomas.
Review in Future oncology (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 269 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
269 citing papers in PubMed, 5 syntheses or guidelines pooled it, 523 citations in OpenAlex.
- Efficacy and safety of 5-aminolevulinic acid in meningioma resection: a systematic review and meta-analysis.Neurosurgical review · 2025Pooled it
- Pooled it
- Peritumoral T2/FLAIR hyperintense MRI findings of meningiomas are not necessarily edema and may persist permanently: a systematic review.Neurosurgical review · 2023Pooled it
- Application of radiomics to meningiomas: A systematic review.Neuro-oncology · 2023Pooled it
- The role of stereotactic radiosurgery in the management of petroclival meningioma: a systematic review.Journal of neuro-oncology · 2022Pooled it
- Phase 2 Trial of PD-1 Inhibitor Sintilimab in Recurrent/Progressive Meningioma.CNS neuroscience & therapeutics · 2025Trial
- Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.Nature communications · 2022Trial
- A Machine Learning Model Based on Unsupervised Clustering Multihabitat to Predict the Pathological Grading of Meningiomas.BioMed research international · 2022Trial
- MRI-based preoperative WHO grade prediction in meningioma: development and comparison of deep learning, radiomics, clinical, and combined models in multicenter data.Journal of neuro-oncology · 2026Article
- Radiation-induced cranial meningiomas are associated with earlier relapse: a propensity score-matched cohort study.Journal of neuro-oncology · 2026Article
- Multiparametric analysis using MRI after preoperative embolization in meningioma: a preliminary study.Radiological physics and technology · 2026Article
- MIB-1 index predicts low recurrence risk after subtotal resection of meningiomas: a retrospective study of 505 patients.Neurosurgical review · 2026Article
- The future of targeted therapies for pediatric central nervous system tumors.Neuro-oncology advances · 2026Review
- Pre-operative embolization of skull base meningiomas.Neuro-oncology advances · 2026Review
- Incidence of radiation necrosis following different radiotherapy fractionation schedules for intracranial meningiomas.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026Article
- When Meningioma Travels: Rare Extracranial Metastasis-Case and Review.Clinical case reports · 2026Article
- Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas.Acta neuropathologica communications · 2026Article
- Human Meningiomas Reveal No Evidence of Neuroendocrine Differentiation.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026Article
- Team-Based Long-Term Multidisciplinary Inpatient Neurological Rehabilitation After Surgery of Cerebral Meningioma-Outcome and Confounding Factors.Brain sciences · 2026Article
- Predictive factors in spinal meningiomas - a comparative analysis with intracranial meningiomas of a high-volume skull and base center.Neurosurgical review · 2026Article
209 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 5 institutions in 2 countries.
Funding
Abstract
Meningiomas are the most common primary intracranial tumor. Important advances are occurring in meningioma research. These are expected to accelerate, potentially leading to impactful changes on the management of meningiomas in the near and medium term. This review will cover the histo- and molecular pathology of meningiomas, including recent 2016 updates to the WHO classification of CNS tumors. We will discuss clinical and radiographic presentation and therapeutic management. Surgery and radiotherapy, the two longstanding primary therapeutic modalities, will be discussed at length. In addition, data from prior and ongoing investigations of other treatment modalities, including systemic and targeted therapies, will be covered. This review will quickly update the reader on the contemporary management and future directions in meningiomas. [Formula: see text].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.